title: [Excessive sweating related to hydromorphone].
abstract: Diffuse and abundant sweating in a middle age patient evolving for several weeks should raise suspicion of malignant lymphoma and infectious or neuroendocrine disorders before considering a drug origin. We report a patient who presented with severe and invalidating excessive sweating related to hydromorphone therapy for vertebral pain. Amongst their many reported side-effects, excessive sweating disappearing with discontinuation of the drug have been reported with some opiates.
authors.affiliation: Service de médecine interne et maladies systémiques, hôpital Général, CHU de Dijon, 3, rue Faubourg-Raines, 21000 Dijon, France. levine_julien@yahoo.com
authors.forename: J
authors.initials: J
authors.lastname: Vinit
authors.forename: H
authors.initials: H
authors.lastname: Devilliers
authors.forename: S
authors.initials: S
authors.lastname: Audia
authors.forename: V
authors.initials: V
authors.lastname: Leguy
authors.forename: H
authors.initials: H
authors.lastname: Mura
authors.forename: N
authors.initials: N
authors.lastname: Falvo
authors.forename: S
authors.initials: S
authors.lastname: Berthier
authors.forename: J-F
authors.initials: JF
authors.lastname: Besancenot
authors.forename: B
authors.initials: B
authors.lastname: Bonnotte
authors.forename: B
authors.initials: B
authors.lastname: Lorcerie
mesh_terms: D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D001416:Back Pain / Q000188:drug therapy; D006801:Humans; D004091:Hydromorphone / Q000008:administration & dosage / Q000009:adverse effects*; D006945:Hyperhidrosis / Q000139:chemically induced*; D008297:Male
chemical_list: D000701:Analgesics, Opioid; D004091:Hydromorphone